Michel Kazatchkine

From Wikipedia, the free encyclopedia
Kazatchkine at "AIDS 2012" sponsored by the International AIDS Society

Michel Kazatchkine is a French physician best known for his work in international AIDS treatment issues. From February 2007 to March 2012 he was director of the The Global Fund to Fight AIDS, Tuberculosis and Malaria. On July 20, 2012, he was appointed as United Nations Special Envoy for HIV/AIDS in Eastern Europe and Central Asia by the UN Secretary-General Ban Ki-moon.[1]

Professional history

Kazatchkine graduated medical school at Necker-Enfants Malades Hospital in Paris then studied immunology at the Pasteur Institute. He first treated AIDS patients in 1983, and by 1985 had founded a clinic in Paris specializing in AIDS treatment.[2]

Kazatchkine directed the French National Agency for AIDS Research between 1998-2005. He is a member of Médecins du Monde and one of the founders of Nova Dona, which is an non-profit organization giving services to drug users in Paris.[2]

In 2005-6 Kazatchkine served The Global Fund to Fight AIDS, Tuberculosis and Malaria as a vice chair, then he became director of the same organization in 2007.[2] In January 2012 the Global Fund officially announced that Kazatchkine will step down in March 2012.[3]

Starting in 2004 Kazatchkine became Chair of the World Health Organization's Strategic and Technical Advisory Committee on HIV/AIDS. At the same time he also began serving as a member of the WHO's Scientific and Technical Advisory Group on tuberculosis.[2]

In February 2005 Kazatchkine became France's HIV/AIDS and communicable diseases global ambassador.[2]

References

  1. UN Press Release
  2. 2.0 2.1 2.2 2.3 2.4 "MICHEL KAZATCHKINE". theglobalfund.org. The Global Fund to Fight AIDS, Tuberculosis and Malaria. Retrieved 7 July 2011. 
  3. The Global Fund (24 January 2012). "THE GLOBAL FUND’S EXECUTIVE DIRECTOR TO STEP DOWN IN MARCH". Retrieved 30 January 2012. 

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.